Celltrion
068270.KS
#771
Rank
C$41.44 B
Marketcap
C$189.44
Share price
1.48%
Change (1 day)
11.39%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2025 (TTM): C$1.19 Billion

According to Celltrion 's latest financial reports the company's current earnings are C$2.94 Billion. , an increase over its 2024 earnings that were of C$0.64 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2025

Annual earnings

Year Earnings Change
2025 C$1.19 B84.38%
2024 C$0.64 B-8.89%
2023 C$0.71 B6.61%
2022 C$0.66 B-21.93%
2021 C$0.85 B10.28%
2020 C$0.77 B65.38%
2019 C$0.46 B16.74%
2018 C$0.40 B-33.93%
2017 C$0.60 B106.65%
2016 C$0.29 B25.18%
2015 C$0.23 B-6.4%
2014 C$0.25 B47.49%
2013 C$0.17 B-33.58%
2012 C$0.25 B
2010 C$0.13 B72.52%
2009 C$77.38 M258.3%
2008 C$21.59 M